154 related articles for article (PubMed ID: 10872181)
1. [Antiarrhythmic effects of pilsicainide hydrochloride and effects on cardiac function and ECG in dogs: comparison with disopyramide].
Hidaka T; Inoue T; Komoriya K; Hayashi Y; Inomata N
Nihon Yakurigaku Zasshi; 2000 May; 115(5):295-308. PubMed ID: 10872181
[TBL] [Abstract][Full Text] [Related]
2. QT-prolonging class I drug, disopyramide, does not aggravate but suppresses adrenaline-induced arrhythmias. Comparison with cibenzoline and pilsicainide.
Miyamoto S; Zhu B; Teramatsu T; Aye NN; Hashimoto K
Eur J Pharmacol; 2000 Jul; 400(2-3):263-9. PubMed ID: 10988343
[TBL] [Abstract][Full Text] [Related]
3. Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: a comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN 1165.
Hashimoto K; Ishii M; Komori S; Mitsuhashi H
Heart Vessels; 1985 Feb; 1(1):29-35. PubMed ID: 2419304
[TBL] [Abstract][Full Text] [Related]
4. Antiarrhythmic effects of optical isomers of disopyramide on canine ventricular arrhythmias.
Nakamura M; Xue Y; Eto K; Hashimoto K
J Cardiovasc Pharmacol; 1996 Mar; 27(3):368-75. PubMed ID: 8907798
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiologic and hemodynamic effects of a single oral dose of pilsicainide hydrochloride, a new class 1c antiarrhythmic agent.
Ino T; Atarashi H; Kuruma A; Onodera T; Saitoh H; Hayakawa H
J Cardiovasc Pharmacol; 1998 Jan; 31(1):157-64. PubMed ID: 9456290
[TBL] [Abstract][Full Text] [Related]
6. Effects of pilsicainide on the atrial fibrillation threshold in guinea pig atria. A comparative study with disopyramide, lidocaine and flecainide.
Inoue M; Inoue D; Ishibashi K; Sakai R; Omori I; Yamahara Y; Asayama J; Nakagawa M
Jpn Heart J; 1993 May; 34(3):301-12. PubMed ID: 8411636
[TBL] [Abstract][Full Text] [Related]
7. Effects of pilsicainide on systemic hemodynamics and cardiac function of anesthetized dogs.
Sakanashi M; Noguchi K; Matsuzaki T; Ojiri Y; Nakasone J; Itomine T; Higuchi M; Shiroma N
Cardioscience; 1993 Dec; 4(4):241-50. PubMed ID: 8298065
[TBL] [Abstract][Full Text] [Related]
8. Canine-effective plasma concentrations of antiarrhythmic drugs on the two-stage coronary ligation arrhythmia.
Hashimoto K; Satoh H; Shibuya T; Imai S
J Pharmacol Exp Ther; 1982 Dec; 223(3):801-10. PubMed ID: 7143241
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of the use-dependent QRS prolongation and the reverse use-dependent QT prolongation of class I and class III antiarrhythmic agents and their value in predicting efficacy.
Sadanaga T; Ogawa S; Okada Y; Tsutsumi N; Iwanaga S; Yoshikawa T; Akaishi M; Handa S
Am Heart J; 1993 Jul; 126(1):114-21. PubMed ID: 8391748
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of pilsicainide hydrochloride for injection in healthy Chinese volunteers: a randomized, parallel-group, open-label, single-dose study.
Qiu Q; Liu W; Li J; Wei Y; Yang K; Suo W; Wu W; Du H; Zhang Y; Zhao G; Zhou Z; Zheng Y; Lin Y
Clin Ther; 2014 Feb; 36(2):255-63. PubMed ID: 24480637
[TBL] [Abstract][Full Text] [Related]
11. Effects of NS-2, a new class 1 antiarrhythmic agent, and AFD-19, its active metabolite, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats: comparison with disopyramide and mexiletine.
Komori S; Sawanobori T; Tamura K; Kane KA; Parratt JR
Jpn J Pharmacol; 1994 Jul; 65(3):193-200. PubMed ID: 7799519
[TBL] [Abstract][Full Text] [Related]
12. Effects of SUN-1165, N-(2,6-dimethylphenyl)-8-pyrrolizidine acetamide hydrochloride hemihydrate, a new class I antiarrhythmic drug, on ventricular arrhythmias, intraventricular conduction, and the refractory period in canine myocardial infarction.
Hashimoto H; Satoh N; Nakashima M
J Cardiovasc Pharmacol; 1992 Mar; 19(3):417-24. PubMed ID: 1378123
[TBL] [Abstract][Full Text] [Related]
13. Rapid infusions of bidisomide or disopyramide in conscious dogs: effect of myocardial infarction on acute tolerability.
Schmidt JJ; Frederick LG; Garthwaite SM
J Cardiovasc Pharmacol; 1992 Aug; 20(2):236-50. PubMed ID: 1381015
[TBL] [Abstract][Full Text] [Related]
14. Effects of antiarrhythmic agents on left ventricular function during exercise in patients with chronic left ventricular dysfunction.
Takada Y; Isobe S; Okada M; Ando A; Nonokawa M; Inden Y; Tomita Y; Suzuki A; Hirai M; Murohara T
Ann Nucl Med; 2004 May; 18(3):209-19. PubMed ID: 15233282
[TBL] [Abstract][Full Text] [Related]
15. A case of sinus pause due to the proarrhythmia of pilsicainide.
Toeda T; Susa R; Saigawa T; Abe T; Yamaguchi Y; Fuse K; Murooka H
Jpn Heart J; 2000 May; 41(3):405-10. PubMed ID: 10987357
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of frequency-dependent conduction delay by class I antiarrhythmic drugs in human atrium.
Sakai R; Inoue D; Ishibashi K; Inoue M; Shirayama T; Yamahara Y; Asayama J; Nakagawa M
J Cardiovasc Pharmacol; 1995 Jun; 25(6):953-60. PubMed ID: 7564341
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of the antiarrhythmic effect of drugs on canine ventricular arrhythmias by the determination of minimum effective plasma concentrations.
Hashimoto K; Shibuya T; Satoh H; Imai S
Jpn Circ J; 1983 Jan; 47(1):92-7. PubMed ID: 6827775
[TBL] [Abstract][Full Text] [Related]
18. An open-label, single-dose, parallel-group, dose-increasing study comparing the pharmacokinetics and tolerability of pilsicainide hydrochloride in healthy Korean and Japanese male subjects.
Kim BH; Kim JR; Lim KS; Kim JW; Kim KP; Hong JH; Jang IJ; Shin SG; Yu KS; Tanaka T
Clin Ther; 2009 Mar; 31(3):609-18. PubMed ID: 19393851
[TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic effects of bisaramil on triggered arrhythmias produced by intracoronary injection of digitalis and adrenaline in the dog.
Haruno A; Hashimoto K
Jpn J Pharmacol; 1995 May; 68(1):95-102. PubMed ID: 7494388
[TBL] [Abstract][Full Text] [Related]
20. Antiarrhythmic effects of combined application of class I antiarrhythmic drugs; addition of low-dose mexiletine-enhanced antiarrhythmic effects of disopyramide and aprindine in various-rate canine ventricular tachycardias.
Awaji T; Hashimoto K
J Cardiovasc Pharmacol; 1993 Jun; 21(6):960-6. PubMed ID: 7687723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
